顺行与交叉股动脉入路治疗重症肢体缺血孤立膝下病变的比较
多中心回顾性研究纳入224例重症肢体缺血患者、292条膝下血管,比较顺行与交叉股动脉入路行腔内治疗的安全性和有效性。总体技术成功率88.4%,两组无显著差异;顺行组入路相关并发症无事件率99%显著高于交叉组90.6%(p=0.022),使用5/6-F鞘管较4-F鞘管并发症风险显著增高(7.1% vs 1.1%,p=0.047)。
要点
- 顺行与交叉股动脉入路治疗孤立膝下病变技术成功率均高且无显著差异
- 顺行入路联合4-F系统可显著降低入路相关并发症
- 较大鞘管(5/6-F)与入路相关并发症风险显著增高相关
核心结论
- 顺行或交叉股动脉入路治疗重症肢体缺血孤立膝下病变均具有高技术成功率和低入路相关并发症发生率。
- 顺行入路使用4-F系统似乎具有显著更低的入路相关并发症率。
研究设计与样本
- 所有患者均为孤立TASC C(n=26)或D(n=198)膝下病变。
- 主要终点为入路相关并发症无事件率和技术成功率,比较顺行与交叉股动脉入路组。
主要发现
- 球囊血管成形术是最常用的治疗方式(169条血管,75.4%)。
- 总体技术成功率为88.4%,顺行组88.0% vs 交叉组90.4%(p>0.99)。
- 全体患者中,狭窄病变技术成功率(100%)高于闭塞病变(85.5%,p=0.002)。
- TASC C膝下病变患者技术成功率(100%)高于TASC D(86.9%,p=0.033)。
- 总体入路相关并发症无事件率为97.8%:顺行组99% vs 交叉组90.6%(p=0.022)。
关键数值与推荐
- 技术成功定义为?原文未明确定义。
- 入路相关并发症无事件率:顺行组99%,交叉组90.6%(p=0.022)。
- 5/6-F鞘管入路相关并发症发生率7.1%,4-F鞘管1.1%(p=0.047)。
临床怎么用
- 对于重症肢体缺血孤立膝下病变的腔内治疗,顺行或交叉股动脉入路均可选择,技术成功率高且入路并发症低。
- 优先考虑顺行入路并使用4-F系统以降低入路相关并发症风险。
- 避免不必要的较大鞘管(5/6-F)以减少入路相关并发症。
局限性
- 回顾性研究设计。
- 样本来自3个中心,可能存在选择偏倚。
- 原文未报告长期随访结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the safety and effectiveness of antegrade vs crossover femoral artery access in the endovascular treatment of isolated below-the-knee (BTK) lesions in patients with critical limb ischemia (CLI). METHODS: Between January 2014 and December 2015, 224 high-risk patients (mean age 75.8±9.8 years; 151 men) with CLI underwent infragenicular interventions on 292 crural vessels in 3 European vascular centers. All patients had isolated TransAtlantic Inter-Society Consensus (TASC) C (n=26) or D (n=198) BTK lesions. Primary endpoints were freedom from access-related complications and technical success comparing the antegrade vs crossover access groups. RESULTS: Balloon angioplasty was the most used treatment modality (169 vessels, 75.4%). The technical success rate was 88.4% in the entire cohort and 88.0% in the antegrade group vs 90.4% in the crossover group (p>0.99). In all patients, the technical success rate was higher for stenotic lesions (100%) vs occlusions (85.5%, p=0.002) and in patients with TASC C BTK lesions (100%) vs TASC D (86.9%, p=0.033). The overall freedom from access-related complications was 97.8%: 99% in the antegrade group and 90.6% in the crossover group (p=0.022). Larger sheath size (5/6-F vs 4-F) was associated with a significantly higher risk for access-related complications (7.1% vs 1.1%, respectively; p=0.047). CONCLUSION: The present multicenter study showed high technical success and a low incidence of access-related complications in the treatment of isolated BTK lesions using either antegrade or crossover femoral access. The antegrade approach with the use of a 4-F system seems to have a significantly lower rate of access-related complications.
引用
- Li Y, Esmail A, Donas KP, et al. Antegrade vs Crossover Femoral Artery Access in the Endovascular Treatment of Isolated Below-the-Knee Lesions in Patients With Critical Limb Ischemia. J Endovasc Ther. 2017. PMID: 28378609. doi:10.1177/1526602817701251
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。